Related Experiment Video
Updated: Nov 23, 2025

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities
Alieh Farshbaf1,2, Nooshin Mohtasham3, Reza Zare3
1Dental Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
The coronavirus disease 2019 (COVID-19) emerges as current outbreak cause by Novel Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). This infection affects respiratory system and provides uncontrolled systemic inflammatory response as cytokine storm. The main concern about SARS-CoV-2 pandemic is high viral pathogenicity with no specific drugs. MicroRNAs (miRs) as small non-coding RNAs (21-25 nt) regulate gene expression. The SARS-CoV-2 encoded-miRs affect human genes that involved in transcription, translation, apoptosis, immune response and inflammation. Also, they alter self-gene regulation and hijacked host miRs that provide protective environment to maintain its latency. On the other hand, Host miRs play critical role in viral gene expression to restrict infection. Over expression/inhibition of miRs might result in cell cycle irregularity, impaired immune response or cancer. In this manner, exact role of each miR should be specified. Mimic encoded-miRs like antagomirs showed successful result in phases of clinical trial prevent from negative effects of viral encoded-miRs. Products of mimic miRs are inexpensive corresponds to synthesis of primer; they are short and nanoscale in size. Although SARS-CoV-2 genome is undergoing evaluation, detection of exact molecular pathogenesis open up opportunities to for vaccine development. Salivaomics can evaluate SARS-CoV-2 genome, transcriptome, proteome and biomarkers like miRs in oral related and cancer disease. In this review, we studied the challenge and opportunities of miRs in therapeutic approach for SARS-CoV-2 infection, then overviewed the role of miRs in saliva droplet during SARS-CoV-2 infection and related cancer.
Insights
MicroRNAs (miRs) play a dual role in COVID-19, with viral miRs targeting human genes and host miRs restricting viral replication. Understanding these miRs offers therapeutic opportunities for SARS-CoV-2 infection and related cancers.
Area of Science:
- Molecular Biology
- Virology
- Genomics
Background:
- COVID-19, caused by SARS-CoV-2, presents a significant global health challenge due to high pathogenicity and lack of specific treatments.
- MicroRNAs (miRs) are small non-coding RNAs that regulate gene expression and are implicated in various biological processes, including immune response and inflammation.
- SARS-CoV-2 infection involves complex interactions between viral and host miRs, affecting critical cellular functions and potentially contributing to disease severity.
Purpose of the Study:
- To review the challenges and opportunities of using miRs as a therapeutic approach for SARS-CoV-2 infection.
- To explore the role of miRs in saliva droplets during SARS-CoV-2 infection and their association with related cancers.
- To highlight the potential of salivaomics in evaluating viral biomarkers like miRs for diagnostic and therapeutic purposes.
Main Methods:
- Literature review of studies investigating the role of miRs in SARS-CoV-2 infection.
- Analysis of miR-host interactions and their impact on viral pathogenesis.
- Examination of therapeutic strategies involving miRs, such as mimic miRs and antagomirs.
- Overview of salivaomics applications in detecting viral components and biomarkers.
Main Results:
- SARS-CoV-2 encoded-miRs can modulate human gene expression involved in immune response, inflammation, and apoptosis.
- Host miRs play a crucial role in controlling viral gene expression and limiting infection.
- Dysregulation of miRs can lead to adverse outcomes, including impaired immune responses and potential oncogenesis.
- Mimic miRs and antagomirs have shown promise in preclinical and clinical trials for mitigating the effects of viral miRs.
Conclusions:
- MicroRNAs represent a promising avenue for therapeutic interventions against SARS-CoV-2 infection.
- Further research into the precise roles of individual miRs is essential for developing targeted therapies.
- Salivaomics offers a non-invasive approach for detecting SARS-CoV-2 and related biomarkers, potentially aiding in early diagnosis and management of infection and associated cancers.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
MicroRNAs
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi

